Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Fubao Huang"'
Publikováno v:
ChemBioChem.
Publikováno v:
ChemBioChem.
Publikováno v:
Medicinal Research Reviews
Inflammation is thought to play an important role in the pathogenesis of vascular diseases. Lipoprotein‐associated phospholipase A2 (Lp‐PLA2) mediates vascular inflammation through the regulation of lipid metabolism in blood, thus, it has been ex
Autor:
Minjun Li, Ruimin Huang, Yishen Liu, Wenwei Xu, Jianhua Shen, Kai Wang, Chengyuan Peng, Yu Zhang, Jing Gao, Hangchen Hu, Hu Zhou, Yechun Xu, Fubao Huang
Publikováno v:
Journal of medicinal chemistry. 63(13)
Covalent ligands are of great interest as therapeutic drugs or biochemical tools. Here, we reported the discovery of highly selective and irreversible inhibitors of lipoprotein-associated phospholipase A2 (Lp-PLA2) using a covalent fragment-based app
Autor:
Kai Wang, Xiaomei Li, Lu Chang, Hui Xu, Jianhua Shen, Fubao Huang, Xiao‐li Zheng, Feifei Lin, Jia Liu, Shilin Li, Haonan Duan, Fanghui Han
Publikováno v:
Analytical and bioanalytical chemistry. 412(13)
In the intestine, several phenols and aromatic acids are generated by microbiota and are highly related to the formation of uremic toxins. Herein, we developed a new derivatization reagent, 2-bromo-1-[4-(dimethylamino)phenyl] ethyl ketone (BDAPE), th
Publikováno v:
Journal of medicinal chemistry. 62(23)
Although intensively expressed within intestine, the precise roles of intestinal dipeptidyl peptidase IV (DPPIV) in numerous pathologies remain incompletely understood. Here, we first reported a nonsystemic intestine-targeted (NSIT) DPPIV inhibitor w
Publikováno v:
Journal of medicinal chemistry. 60(24)
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a promising therapeutic target for atherosclerosis, Alzheimer's disease, and diabetic macular edema. Here we report the identification of novel sulfonamide scaffold Lp-PLA2 inhibitors derived from
Publikováno v:
Journal of Medicinal Chemistry; 12/28/2017, Vol. 60 Issue 24, p10231-10244, 14p